Brand Name
Caldolor
Broad Category
Analgesic / Antipyretic / NSAID
Pharm Class
Proprionic acid derivative
Nonselective COX
MOA
nonselectively Inhibits COX isoenzymes preventing the synthesis of prostaglandins and thromboxane
Indications / Clinical uses
Pain management
ERAS Protocols
Antipyretic?
IV dose
400-800 mg over 30 mins q6h
Pediatric IV dose (12-17 years)
400 mg over 30 mins q4-6h
Administration Safety note
MUST BE DILUTED PRIOR TO USE
- undiluted can cause hemolysis
- must be delivered slow and never as IV bolus or IM injection
MAX dose (daily)
3200 mg/day
Onset
30 mins
Duration
4-6 hours
Common SE ( > 5%)
N/V
flatulence
HA
hemorrhage
dizziness
Most common adverse reactions in peds (>/= 2%)
infusion site pain
N/V
anemia
HA
Hematologic effects
bleeding
GI effects
Gastropathy
GI bleeding
Peptic ulcer disease
CV effects
HTN
HF exacerbation
increased risk of VTE, MI, and Stroke
Renal effects
induce reversible GFR impairment
Skeletal effects
Potential to inhibit bone formation and delay secondary bone healing
Absolute contraindications
KNOWN HYPERSENSITIVITY
- Anaphylactoid or serious skin reactions
Samter’s Triad (AERD)
- Asthma
- urticaria
- other allergic-type reactions after taking aspirin or other NSAIDs
Pregnancy after 30 weeks gestation
Precautions
CV disease
Peptic ulcer disease
GI bleeding
Liver disease
HTN
Heart failure
Metabolism
Extensive Hepatic
- CYP2C9
Elimination
Renal excretion
Vd coniderations
Small
- hydrophilic
- remains in plasma / ECF
Clearance considerations
Reduced by
- hepatic impairment
- elderly